ACHIEVE LIFE SCIENCES INC
ACHVNASDAQπ #2534 by market capEarnings Mar 22 Β· PostUS Equity
$6.78β² $0.06 (+0.89%)
Market closed Β· at closeTrack ACHV
Get earnings, price moves & breaking news on Telegram
24hβ² 0.9%
7dβΌ 0.3%
14dβ² 0.9%
30dβ² 4.7%
ytdβ² 36.1%
1yβ² 71.9%
π¦Market Cap
$698M
Small Cap
πRevenue Growth (YoY)
-89.3%
Declining
πGross Margin
β
π΅FCF Margin
34.0%
Strong
βοΈP/S Ratio
39.2x
Expensive
Otter Score
β
Insufficient data
Trading Snapshot
- Day Range
- $6.52 β $6.91
- 52-Week Range
- $2.62 β $8.64
- Volume (shares)
- 1,088,136
- Avg Volume (shares)
- β
- Shares Outstanding
- 102.9M
- Next Earnings
- 2027-03-22
Fundamentals Snapshot
- Annual Revenue
- β
- Last Q Revenue
- $114,000
- P/E Ratio
- β
- P/S Ratio
- 39.2x
- EPS (TTM)
- $-1.55
- Dividend Yield
- β
- Dilution (1yr)
- +54.4%
ACHIEVE LIFE SCIENCES INC
ACHVFinancial Trends
RevenueThe total money the company brought in from sales, before subtracting any costs.
$0
Operating IncomeProfit from the core business after operating costs, but before interest and taxes. Negative means the core business isnβt profitable yet.
β$55Mβ² +40.5% YoY
Free Cash FlowCash left over after running the business and paying for equipment/capex. Negative means the company is burning cash.
β$49Mβ² +66.2% YoY
Shares OutstandingHow many shares exist. Rising means the company is issuing more shares, which dilutes (shrinks) each existing ownerβs slice.
53.3Mβ² +54.4% YoY
Net CashCash minus total debt. Positive = more cash than debt (financially strong); negative = more debt than cash (net debt).
$6Mβ² +$3M YoY
About ACHIEVE LIFE SCIENCES INC
Achieve Life Sciences, Inc. operates as a clinical-stage pharmaceutical firm, concentrating on the development and market introduction of cytisinicline. This compound is aimed at assisting with smoking cessation and nicotine dependence, with commercial activities spanning Canada, the United States, and the United Kingdom. Cytisinicline is a naturally occurring alkaloid, which functions by engaging with nicotine receptors in the brain to lessen the intensity of nicotine withdrawal symptoms. The company holds licensing agreements with Sopharma AD and the University of Bristol. Its corporate headquarters are located in Vancouver, Canada.
π¦¦
Otter Score Breakdown
How it's scoredFive components, each rated 1β5β and equally weighted (20%), averaged to a 0β100 score:π Quality β gross marginπ Growth β revenue YoYβοΈ Valuation β P/S ratioβ‘ Momentum β 30-day price changeπ§ Dilution β 1-yr share issuance (buybacks score higher)Insufficient data for all five components.
πGrowthβ
β
β
β
β
βοΈValuationβ
β
β
β
β
β‘Momentumβ
β
β
β
β
π§Dilutionβ
β
β
β
β
Overall Score
Insufficient data
β/100
Analyst Ratings
βConsensus
Buy
18 analysts
Strong Buy4
Buy13
Hold1
Sell0
Strong Sell0
Ratings as of Nov 2026
Latest News & Updates
News unavailable.